GRENEZ-OCMANT
ActiveSummary
GRENEZ-OCMANT has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €476k and a net result of €118k. Equity is growing by ~2.8% per year across the filed fiscal years. Its solvency ranks better than 77% of 18280 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
85
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability89▲+1
Solvency92▼-8
Growth78=
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity ample (current ratio 3.38 against 8.89 in 2024; short-term debt: 26% and cash: 43.9% of total assets), and 33.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
66.8%
Return on assets
16.5%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
27 d late
2024
27 d late
2023
19 d late
2022
24 d early
2021
16 d early
2020
32 d early
2019
17 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€476k▼ 19.1%
2024 · €588k
2018: €407k
2019: €468k
2020: €405k
2021: €448k
2022: €474k
2023: €473k
2024: €588k
2018 → 2025
Total assets
€712k▼ 3.8%
2024 · €740k
2018: €516k
2019: €537k
2020: €631k
2021: €689k
2022: €692k
2023: €713k
2024: €740k
2018 → 2025
Net result
€118k▲ 2.4%
2024 · €115k
2018: €45k
2019: €103k
2020: €105k
2021: €127k
2022: €125k
2023: €110k
2024: €115k
2018 → 2025
Working capital
€440k▼ 20.1%
2024 · €551k
2018: €395k
2019: €465k
2020: €399k
2021: €447k
2022: €465k
2023: €430k
2024: €551k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€448k-€474k▲ 5.7%€473k▼ 0.2%€588k▲ 24.3%€476k▼ 19.1%
Operating result€192k-€186k▼ 2.8%€163k▼ 12.4%€167k▲ 2.4%€181k▲ 8.4%
Net result€127k-€125k▼ 2.1%€110k▼ 11.5%€115k▲ 4.3%€118k▲ 2.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 8% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €712k
Fixed assets
€87k ▼ 27.1%
Current assets
€625k ▲ 0.7%
Equity and liabilities €712k
Equity
€476k ▼ 19.1%
Debt
€237k ▲ 55.3%
Debt's share of the balance-sheet total rises from 20.6% to 33.2%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€217k▲
2024 · €203k
Cash flow
€153k▲
2024 · €151k
Current ratio
3.38▼
2024 · 8.89
Debt to equity
0.50▲
2024 · 0.26
ROE
24.8%▲
2024 · 19.6%
ROA
16.5%▲
2024 · 15.5%
Interest coverage
28.83▲
2024 · 23.93
Debt ≤ 1 year
€185k▲
2024 · €70k
Debt > 1 year
€52k▼
2024 · €82k
Income taxes
€57k▲
2024 · €50k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 50 lines
Balance sheet
Code20242025
Assets
Total assets20/58€740k€712k▼
Fixed assets21/28€120k€87k▼
Tangible fixed assets22/27€120k€87k▼
Furniture and vehicles24€120k€87k▼
Financial fixed assets28€50€50=
Current assets29/58€620k€625k▲
Amounts receivable after more than one year29-€2k
Other amounts receivable291-€2k
Amounts receivable within one year40/41€56k€65k▲
Trade receivables40€38k€32k▼
Other amounts receivable41€18k€33k▲
Current investments50/53-€200k
Cash at bank and in hand54/58€519k€313k▼
Deferred charges and accrued income490/1€45k€45k▲
Equity and liabilities
Total equity and liabilities10/49€740k€712k▼
Equity10/15€588k€476k▼
Contributions10/11€6k€6k=
Reserves13€582k€469k▼
Distributable reserves133€582k€469k▼
Profit (loss) carried forward14€28€28▲
Amounts payable17/49€152k€237k▲
Amounts payable after more than one year17€82k€52k▼
Financial debts170/4€82k€52k▼
Amounts payable within one year42/48€70k€185k▲
Current portion of amounts payable after more than one year42€30k€31k▲
Trade debts44€2k€3k▲
Suppliers440/4€2k€3k▲
Taxes, remuneration and social security45€10k€33k▲
Taxes450/3€10k€33k▲
Other amounts payable47/48€28k€119k▲
Accrued charges and deferred income492/3€122€87▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€36k€35k▼
Other operating charges640/8€4k€4k▼
Gross operating margin9900€207k€220k▲
Operating profit (loss)9901€167k€181k▲
Financial income75/76B€6k€1k▼
Recurring financial income75€6k€1k▼
Financial charges65/66B€8k€8k▼
Recurring financial charges65€8k€8k▼
Profit (loss) for the period before taxes9903€165k€175k▲
Income taxes67/77€50k€57k▲
Profit (loss) for the period9904€115k€118k▲
Profit (loss) for the period to be appropriated9905€115k€118k▲
Appropriation of the result
Profit (loss) to be appropriated9906€115k€118k▲
Profit (loss) brought forward from the previous period14P€14€28▲
Transfer from equity791/2€0€230k▲
Transfer to equity691/2€115k€118k▲
To other reserves6921€115k€118k▲
Profit to be distributed694/7€0€230k▲
Return on contributions (dividend)694€0€230k▲
The notes to these accounts (17 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 27 days late
2025
27-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 27 days late
2024
31-12
Financial
Liquidity doublescurrent ratio 8.89
Current ratio from 4.36 to 8.89; short-term debt falls from €128k to €70k.
31-12
Financial
Equity above €500kEq €588k ▲24.3%
7 profitable years in a row build equity to €588k.
19-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 19 days late
2023
07-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
15-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Highest result since 2018net €127k ▲20.6%
Operating result €192k, net result €127k, both a record.
29-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
14-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
15-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
18-06
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
01-09
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 32 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Le Roeulx · 1 establishment unit since 2011
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Chaussée de Soignies(R) 1147070 Le RoeulxGround area
2,099 m²
Building footprint
216 m²
Parcel 55542A0414/00P000, Wallonia. Linked by address, not a title deed.
1 establishment unit
Chaussée de Soignies(R) 114, 7070 Le Roeulx
since 20112.206.675.566
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 55542A0414/00P000 | Wallonia | 2,099 m² | 1 · 216 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Masy Pharma
BE 0429.997.139
Vilvoorde · Eq €475,544
APOTHEEK JACOBS
BE 0447.070.525
Lievegem · Eq €475,538
VANLERBERGHE INVEST
BE 0846.206.917
Torhout · Eq €475,312
APOTHEEK HAVERMARKT
BE 0449.811.665
Hasselt · Eq €475,300
APOTHEEK CLAES
BE 0407.180.462
Balen · Eq €475,283
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,375 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded14-12-2011
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
86910Medical imaging and medical laboratories
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.